We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
-17.07%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$1.52B
AUM Growth
-$55.5M
Cap. Flow
+$168M
Cap. Flow %
11.04%
Top 10 Hldgs %
38.58%
Holding
149
New
11
Increased
70
Reduced
43
Closed
11

Top Buys

Rank Stock Value
1
ALGN icon
Align Technology
ALGN
+$41.6M
2
ILMN icon
Illumina
ILMN
+$33.2M
3
TDOC icon
Teladoc Health
TDOC
+$29.8M
4
ISRG icon
Intuitive Surgical
ISRG
+$25.9M
5
ABT icon
Abbott
ABT
+$14.7M

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$17.1M
2
KTWO
K2M Group Holdings, Inc
KTWO
+$15.1M
3
EW icon
Edwards Lifesciences
EW
+$14.5M
4
PACB icon
Pacific Biosciences
PACB
+$13.9M
5
LH icon
Labcorp
LH
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 88.15%
2 Industrials 0.99%
3 Technology 0.52%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ILMN icon
1
Illumina
ILMN
$28.2B
$75.5M 4.97%
258,946
+107,103
+71% +$33.2M
ABT icon
2
Abbott
ABT
$175B
$70.6M 4.64%
976,451
+209,741
+27% +$14.7M
OEF icon
3
CALL
iShares S&P 100 ETF
OEF
$20.1B
$70M 4.6%
+200
New +$24.1K
ISRG icon
4
Intuitive Surgical
ISRG
$122B
$66.5M 4.37%
416,391
+152,787
+58% +$25.9M
ALGN icon
5
Align Technology
ALGN
$12.7B
$65.1M 4.28%
310,795
+164,485
+112% +$41.6M
ELV icon
6
Elevance Health
ELV
$80.9B
$61.1M 4.02%
232,660
+8,472
+4% +$2.33M
TDOC icon
7
Teladoc Health
TDOC
$1.7B
$53.2M 3.5%
1,073,839
+487,319
+83% +$29.8M
MDT icon
8
Medtronic
MDT
$106B
$45.2M 2.97%
496,446
– –
CELG
9
DELISTED
Celgene Corp
CELG
$42.1M 2.77%
657,601
+51,601
+9% +$3.81M
BSX icon
10
Boston Scientific
BSX
$65.4B
$37.4M 2.46%
1,056,889
+77,960
+8% +$2.83M
DHR icon
11
Danaher
DHR
$144B
$34.3M 2.26%
375,507
+90,105
+32% +$8.18M
UNH icon
12
UnitedHealth
UNH
$387B
$33.1M 2.18%
132,836
+8,988
+7% +$2.37M
JAZZ icon
13
Jazz Pharmaceuticals
JAZZ
$15.5B
$32.3M 2.12%
260,648
+46,890
+22% +$6.96M
CI icon
14
Cigna
CI
$74.5B
$31.5M 2.07%
165,625
-3,838
-2% -$801K
BDX icon
15
Becton Dickinson
BDX
$43.6B
$27.5M 1.81%
124,919
+16,871
+16% +$3.92M
BMY icon
16
Bristol-Myers Squibb
BMY
$124B
$25.3M 1.66%
486,824
+145,095
+42% +$7.8M
EW icon
17
Edwards Lifesciences
EW
$49.4B
$24.2M 1.59%
473,391
-286,608
-38% -$14.5M
SYK icon
18
Stryker
SYK
$123B
$23.6M 1.55%
150,834
+9,454
+7% +$1.58M
HUM icon
19
Humana
HUM
$48B
$22.5M 1.48%
78,660
-19,850
-20% -$6.29M
ESPR
20
DELISTED
Esperion Therapeutics
ESPR
$20.8M 1.37%
451,972
+60,120
+15% +$2.9M
IONS icon
21
Ionis Pharmaceuticals
IONS
$8.99B
$20.7M 1.36%
382,588
+72,052
+23% +$3.67M
WCG
22
DELISTED
Wellcare Health Plans, Inc.
WCG
$19.6M 1.29%
83,204
+54,935
+194% +$14.7M
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$123B
$19M 1.25%
114,700
+74,206
+183% +$12.9M
WMGI
24
DELISTED
Wright Medical Group Inc
WMGI
$18.5M 1.21%
678,114
+55,422
+9% +$1.53M
COR icon
25
Cencora
COR
$59.9B
$18.4M 1.21%
246,762
+7,909
+3% +$682K
1
2 3 4 5

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Bellevue Group's Q4 2018 Portfolio in Review

As of Q4 2018, Bellevue Group held 149 positions worth $1.52B, down 3.5% from $1.58B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Bellevue Group deployed $168M of net new capital in Q4 2018, opening 11 new positions and adding to 70 existing holdings. Its largest new stake was QuidelOrtho: 125,000 shares worth $6.1M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 93% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Centene, an estimated $17.1M trimmed.

  • Bellevue Group's largest Q4 2018 buy was QuidelOrtho: 125,000 shares worth $6.1M.
  • Bellevue Group added most to Align Technology in Q4 2018, an estimated $41.6M increase.
  • Bellevue Group's biggest Q4 2018 reduction was Centene, cutting an estimated $17.1M.
  • Bellevue Group fully exited K2M Group Holdings, Inc in Q4 2018, selling an estimated $15.1M.
  • Bellevue Group's ten largest holdings make up 39% of its $1.52B portfolio in Q4 2018.
  • Bellevue Group opened 11 new positions and closed 11 in Q4 2018.
  • Bellevue Group's portfolio value fell 3.5% quarter-over-quarter to $1.52B.

Based on Bellevue Group's 13F filing for Q4 2018, filed 12 Feb 2019.